Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,400 | 265 | 70.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 6 | 21.6% |
| Consulting Fee | $400.00 | 1 | 3.8% |
| Education | $381.46 | 17 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hologic, LLC | $2,478 | 14 | $0 (2021) |
| ABBVIE INC. | $1,222 | 52 | $0 (2024) |
| Baxter Healthcare | $788.52 | 17 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $620.80 | 19 | $0 (2019) |
| Duchesnay USA Incorporated | $608.95 | 10 | $0 (2019) |
| Myovant Sciences Inc. | $417.66 | 12 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $416.45 | 13 | $0 (2024) |
| Cook Medical LLC | $400.00 | 1 | $0 (2017) |
| Allergan Inc. | $300.88 | 18 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $296.60 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $547.07 | 14 | MIMEDX Group, Inc. ($141.39) |
| 2023 | $656.40 | 21 | Sumitomo Pharma America, Inc. ($343.34) |
| 2022 | $1,134 | 37 | Myovant Sciences Inc. ($363.21) |
| 2021 | $1,061 | 35 | AbbVie Inc. ($290.11) |
| 2020 | $464.50 | 24 | AbbVie Inc. ($185.80) |
| 2019 | $1,112 | 44 | AbbVie, Inc. ($321.63) |
| 2018 | $1,893 | 64 | Duchesnay USA Incorporated ($561.99) |
| 2017 | $3,564 | 50 | HOLOGIC INC ($2,397) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: WOMENS HEALTH | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: HORMONE THERAPY | ||||||
| 09/26/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $141.39 | General |
| 08/22/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 07/30/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: HORMONE THERAPY | ||||||
| 07/16/2024 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device), MYOSURE TISSUE REMOVAL DEVICE | Food and Beverage | In-kind items and services | $129.97 | General |
| Category: Surgical | ||||||
| 06/14/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $41.24 | General |
| Category: Surgical Care | ||||||
| 05/10/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Surgical Care | ||||||
| 04/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: HORMONE THERAPY | ||||||
| 03/08/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Surgical Care | ||||||
| 03/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Biological | ||||||
| 02/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: HORMONE THERAPY | ||||||
| 12/19/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: HORMONE THERAPY | ||||||
| 12/07/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Immunology | ||||||
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Biological | ||||||
| 10/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Biological | ||||||
| 10/10/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $112.62 | General |
| Category: HORMONE THERAPY | ||||||
| 10/06/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: HORMONE THERAPY | ||||||
| 09/28/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Oral Contraceptive | ||||||
| 08/16/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: HORMONE THERAPY | ||||||
| 07/28/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: HORMONE THERAPY | ||||||
| 07/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Biological | ||||||
| 07/05/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 39 | 41 | $11,667 | $2,724 |
| 2022 | 3 | 38 | 38 | $11,674 | $2,698 |
| 2021 | 1 | 19 | 19 | $2,793 | $898.32 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $4,521 | $1,102 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $4,634 | $1,005 | 21.7% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 16 | 16 | $2,512 | $617.60 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $5,754 | $1,217 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $4,303 | $954.69 | 22.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 11 | 11 | $1,617 | $526.47 | 32.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 19 | 19 | $2,793 | $898.32 | 32.2% |
About Dr. Robert Berg, M.D
Dr. Robert Berg, M.D is a Obstetrics & Gynecology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336105436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Berg, M.D has received a total of $10,432 in payments from pharmaceutical and medical device companies, with $547.07 received in 2024. These payments were reported across 289 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,400).
As a Medicare-enrolled provider, Berg has provided services to 96 Medicare beneficiaries, totaling 98 services with total Medicare billing of $6,321. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location New York, NY
- Active Since 04/26/2006
- Last Updated 03/29/2023
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1336105436
Products in Payments
- MyoSure (Device) $1,500
- MYFEMBREE (Drug) $834.11
- NovaSure (Device) $750.00
- Osphena (Drug) $608.95
- INTRAROSA (Drug) $565.76
- LO LOESTRIN FE (Drug) $437.29
- ORILISSA (Drug) $429.93
- Orilissa (Drug) $365.55
- INJECTAFER (Drug) $247.61
- OVA1 (Device) $205.94
- NUVARING (Drug) $191.24
- Balcoltra (Drug) $175.25
- Kyleena (Drug) $149.66
- TISSEEL (Biological) $147.44
- Prolia (Biological) $133.20
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $131.51
- ACESSA PROVU SYSTEM (Device) $129.97
- Xulane (Drug) $127.44
- FLOSEAL (Biological) $126.97
- FLOSEAL (Device) $121.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in New York
Mary Polan, M.d, M.D
Obstetrics & Gynecology — Payments: $2.3M
Steven Goldstein, Md, MD
Obstetrics & Gynecology — Payments: $831,948
Veronica Lerner, Md, MD
Obstetrics & Gynecology — Payments: $233,429
Jian Qun Huang, M.d, M.D
Obstetrics & Gynecology — Payments: $212,396
Carolyn Westhoff, M.d, M.D
Obstetrics & Gynecology — Payments: $185,820
Dr. Lisa Eng, D.o, D.O
Obstetrics & Gynecology — Payments: $178,012